AVROXA
0687.774.936 · rovalta.com · 04/11/2026
AVROXA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOAVROXA is a Private limited company incorporated in 2018. Its main activity is: Manufacture of other organic basic chemicals. Its registered office is in Gent. It employs on average 1,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0687.774.936
- Incorporation
- 10/01/2018
- Legal form
- Private limited company
- Registered office
- Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,0 ETP
Joint committees (2)
- 2070
- 207000
Financials
Source · NBB, 8 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 170,8 k € | -84.9% | 1,1 M € | +12.2% | 1 M € | +185% | 354,7 k € | +7.6% | 329,5 k € |
| EBITDA | 95,9 k € | -91.0% | 1,1 M € | +17.9% | 901,2 k € | +391% | 183,4 k € | +24.8% | 146,9 k € |
| Operating result | -36,1 k € | -104% | 961,9 k € | +41.2% | 681,2 k € | +1631% | -44,5 k € | -39.6% | -31,9 k € |
| Net result | -32,5 k € | -104% | 815 k € | +41.4% | 576,6 k € | +1363% | -45,7 k € | -33.3% | -34,3 k € |
| Balance sheet | |||||||||
| Equity | 869 k € | -44.9% | 1,6 M € | +107% | 760,8 k € | +183% | 268,8 k € | -38.6% | 437,9 k € |
| Total assets | 1,8 M € | -6.4% | 1,9 M € | +89.2% | 1 M € | +128% | 445,5 k € | -31.8% | 653,4 k € |
| Cash | 1,5 M € | +14.7% | 1,3 M € | +95.2% | 671,9 k € | +296% | 169,7 k € | -32.2% | 250,1 k € |
| Debts | 903,2 k € | +204% | 296,9 k € | +88.5% | 157,5 k € | +50.7% | 104,5 k € | -22.3% | 134,5 k € |
| Other | |||||||||
| Workforce | 1,0 ETP | 0.0% | 1,0 ETP | – | – | – | |||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Richard Hoogenboom | Directorsince 05/01/2018Mandate2019 accountsendedManager2018 accountsended | ||
Victor Retamero De La Rosa | Directorsince 05/01/2018Mandate2019 accountsendedManager2018 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
An Van Den Bulcke | Mandate2019 accountsManager2018 accounts |
Other companies at this address
Technologiepark-Zwijnaarde 82 9052 Gent| Company | CBE no. |
|---|---|
Amalus Therapeutics● Bankrupt | 0803.929.268 |
APCOR R&M● Active | 0600.952.909 |
Ardoyen● Active | 0875.102.821 |
Benebiose● Active | 0784.521.548 |
BioNeering● Active | 0807.194.309 |
CONTREL EUROPE● Active | 0426.204.637 |
CRODEON TECHNOLOGIES● Active | 0642.754.761 |
Cryptobiotix● Active | 0762.565.104 |
Gulliver Biomed● Active | 0692.527.837 |
ImplicitMeasures.com● Bankrupt | 0657.989.701 |
Inbiose● Active | 0534.887.593 |
| 0440.054.752 | |
INNOVATIVE PHARMACEUTICS● Active | 0883.574.582 |
Inspect● Active | 0645.950.417 |
INVIBES ADVERTISING● Active | 0836.533.938 |
KYTOS● Active | 0768.755.286 |
Lares Solutions● Active | 1015.346.906 |
| 0755.350.975 | |
| 0742.910.132 | |
| 0667.765.816 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/07/2026 | 23/12/2025 | 01/10/2024 | 30/08/2023 | 24/08/2022 | 13/08/2021 |
| General meeting | 20/06/2026 | 31/10/2025 | 31/08/2024 | 29/08/2023 | 30/07/2022 | 31/07/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 20/06/2026 | 16/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 31/10/2025 | 23/12/2025 | Dutch | |
| Micro model | 31/12/2023 | 31/08/2024 | 01/10/2024 | Dutch | |
| Micro model | 31/12/2022 | 29/08/2023 | 30/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 30/07/2022 | 24/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 31/07/2021 | 13/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 20/06/2020 | 13/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 15/06/2019 | 10/07/2019 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Richard Hoogenboom | Directorsince 05/01/2018Mandate2019 accountsendedManager2018 accountsended | ||
Victor Retamero De La Rosa | Directorsince 05/01/2018Mandate2019 accountsendedManager2018 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
An Van Den Bulcke | Mandate2019 accountsManager2018 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates30/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Mandates18/05/2021ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
- Registered office25/01/2019MAATSCHAPPELIJKE ZETEL
- Other12/01/2018RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Technologiepark-Zwijnaarde 82, 9052 ZwijnaardeCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00299448 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| AVROXACurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00299448 |
Events
- 2025Annual accounts 2025-32,5 k €↓
- 2024Annual accounts 2024815 k €↑
- 2023Annual accounts 2023576,6 k €↑
- 2022Annual accounts 2022-45,7 k €↓
- 2021Annual accounts 2021-34,3 k €↓
- 2019Annual accounts 2019190,2 k €↑
- 2018Annual accounts 201824,4 k €
- 10/01/2018IncorporationPrivate limited company